
Published online:
01 October 2014
Published in print:
01 July 2014
Online ISBN:
9780191781780
Print ISBN:
9780198713340
Contents
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
14.1 Background 14.1 Background
-
14.2 Epidemiology and sequelae of fragility fractures in men 14.2 Epidemiology and sequelae of fragility fractures in men
-
14.2.1 Overview 14.2.1 Overview
-
14.2.2 Mortality 14.2.2 Mortality
-
14.2.3 Morbidity 14.2.3 Morbidity
-
-
14.3 Pathogenesis of fragility fractures in men 14.3 Pathogenesis of fragility fractures in men
-
14.3.1 Overview 14.3.1 Overview
-
14.3.2 Skeletal geometry 14.3.2 Skeletal geometry
-
14.3.3 Bone turnover 14.3.3 Bone turnover
-
14.3.4 Age-related bone loss 14.3.4 Age-related bone loss
-
14.3.5 BMD in men who fracture 14.3.5 BMD in men who fracture
-
14.3.6 The role of sex steroids 14.3.6 The role of sex steroids
-
14.3.7 Secondary causes of osteoporosis 14.3.7 Secondary causes of osteoporosis
-
-
14.4 Diagnosis of osteoporosis in men 14.4 Diagnosis of osteoporosis in men
-
14.4.1 Overview 14.4.1 Overview
-
-
14.5 Investigation of osteoporosis in men 14.5 Investigation of osteoporosis in men
-
14.6 Management of osteoporosis in men 14.6 Management of osteoporosis in men
-
14.7 Treatment of osteoporosis in men 14.7 Treatment of osteoporosis in men
-
14.7.1 Bisphosphonates 14.7.1 Bisphosphonates
-
14.7.2 Teriparatide 14.7.2 Teriparatide
-
14.7.3 Alternative agents 14.7.3 Alternative agents
-
-
14.8 Conclusions 14.8 Conclusions
-
Key references Key references
-
-
-
-
-
-
-
-
-
-
Cite
Hanusch, Birgit C., Stephen P. Tuck, and Roger M. Francis, 'Osteoporosis in men', in Gavin Clunie, and Richard W. Keen (eds), Osteoporosis, 2 edn, Oxford Medical Handbooks (Oxford , 2014; online edn, Oxford Academic, 1 Oct. 2014), https://doi.org/10.1093/med/9780198713340.003.0014, accessed 17 Apr. 2025.
Abstract
•
Male osteoporosis is common, with a 1 in 5 lifetime risk of fracture over the age of 50 years.
•
Male osteoporosis is both underdiagnosed and undertreated.
•
Men with fractures have higher mortality than men without fractures, and this is higher than that found in women.
•
Secondary causes are very common in men with osteoporosis.
•
There is now evidence for the use of oral and intravenous bisphosphonates, strontium ranelate, teriparatide, and denosumab to treat male osteoporosis.
Subject
Rheumatology
Series
Oxford Rheumatology Library
Collection:
Oxford Medicine Online
Disclaimer
Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct.
Readers must therefore always …
More
Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct.
Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets
provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or
legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages
and recommendations are for the non-pregnant adult who is not breastfeeding.
© Oxford University Press
You do not currently have access to this chapter.
Sign in
Personal account
- Sign in with email/username & password
- Get email alerts
- Save searches
- Purchase content
- Activate your purchase/trial code
- Add your ORCID iD
Purchase
Our books are available by subscription or purchase to libraries and institutions.
Purchasing informationMetrics
View Metrics
Metrics
Total Views
7
6
Pageviews
1
PDF Downloads
Since 4/1/2024
Month: | Total Views: |
---|---|
April 2024 | 1 |
July 2024 | 4 |
September 2024 | 2 |
Citations
Altmetrics
Get help with access
Institutional access
Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:
IP based access
Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.
Sign in through your institution
Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.
If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.
Sign in with a library card
Enter your library card number to sign in. If you cannot sign in, please contact your librarian.
Society Members
Society member access to a journal is achieved in one of the following ways:
Sign in through society site
Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:
If you do not have a society account or have forgotten your username or password, please contact your society.
Sign in using a personal account
Some societies use Oxford Academic personal accounts to provide access to their members. See below.
Personal account
A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.
Some societies use Oxford Academic personal accounts to provide access to their members.
Viewing your signed in accounts
Click the account icon in the top right to:
Signed in but can't access content
Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.
Institutional account management
For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.